Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer
Status:
Active, not recruiting
Trial end date:
2022-12-20
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate clinical efficacy and safety of bintrafusp alfa
in participants with advanced, unresectable cervical cancer with disease progression during
or after platinum-containing chemotherapy.